Cardiac conditioning ameliorates cardiac dysfunction associated with renal hypertension in rats

Insights

Physiologic hypertrophy from swimming training improved cardiac function in hypertensive rats, demonstrating distinct biological properties and potential to mitigate pathological effects.

Area of Science:

  • Cardiovascular Physiology
  • Exercise Physiology
  • Pathology

Background:

  • Pathologic hypertrophy in renal hypertensive rats leads to diminished cardiac function.
  • Physiologic hypertrophy, induced by exercise, may influence cardiac adaptation.
  • Understanding the interplay between these hypertrophy types is crucial for cardiac health.

Purpose of the Study:

  • To investigate the effects of superimposed physiologic hypertrophy on pathologic hypertrophy in a rat model.
  • To determine if exercise training can restore cardiac function in hypertensive hearts.
  • To differentiate the biological characteristics of physiologic and pathologic hypertrophy.

Main Methods:

  • Isolated working rat-heart perfusion apparatus used to assess cardiac function.
  • Comparison of four groups: control, renal hypertensive, swimming-trained, and swimming-trained hypertensive rats.
  • Measurement of cardiac output, ejection fraction, fractional shortening, and coronary flow.

Main Results:

  • Swimming training increased heart weight in both control and hypertensive rats.
  • Hypertensive hearts showed depressed cardiac output and function, while swimming-trained hearts showed enhanced function.
  • Swimming training partially restored cardiac function in hypertensive rats, with normalized ejection fraction and fractional shortening.
  • Coronary flow was depressed in hypertensive hearts but partially restored with training; elevated lactate/pyruvate ratios indicated altered metabolism in trained hypertensive hearts.

Conclusions:

  • Physiologic hypertrophy is biologically distinct from pathologic hypertrophy.
  • Exercise-induced physiologic hypertrophy can partially ameliorate cardiac dysfunction associated with pathologic hypertrophy.
  • Superimposing training on hypertensive hearts improves cardiac performance despite increased overall hypertrophy.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K